End-to-End Clinical Trial & CRO Services in Korea
Empowering Your Growth in South Korea with All-in-One GxP and Regulatory Services
South Korea is rapidly emerging as a global hub for pharmaceuticals, biotechnology, skincare, and health supplements, driven by innovation, advanced research, and evolving consumer demands.
To succeed in this dynamic market, businesses must align with South Korea’s evolving regulatory requirements and quality standards. Zenovel’s regulatory and scientific solutions help organizations ensure compliance, accelerate market entry, and maintain product safety, quality, and efficacy across pharmaceuticals, biotech, cosmetics, and nutraceuticals.
Good Clinical Practice (GCP) Services in Korea for Clinical Trial Compliance
We Ensure GCP Excellence for Compliant Clinical Trials Across South Korea
Clinical trials in South Korea are regulated by the Ministry of Food and Drug Safety (MFDS) under the Korea Good Clinical Practice (KGCP) guidelines, aligned with ICH GCP standards. Since becoming a full ICH member in 2016, South Korea ranks 6th globally in clinical trials, holding a 3.46% share of sponsor-driven trials. The adoption of ICH E6(R3) principles emphasizes the importance of GCP compliance for sponsors in this competitive clinical research environment.
Zenovel offers GCP compliance services in South Korea, assisting sponsors, CROs, and biotech firms in understanding the MFDS regulatory framework and ensuring their clinical operations are inspection-ready.
Our GCP Compliance Services in South Korea Include the following:
- Audit Support, Quality System Evaluation & Inspection Readiness
- Risk‑Based Compliance Assessments & Deviation Management
- Site Oversight, Vendor Compliance & CAPA Implementation
- Audit Trail Reviews & Documentation Control
At Zenovel, we work with your clinical and quality teams to create effective compliance frameworks that ensure real-world inspection readiness. Our extensive global regulatory expertise aims to minimize compliance uncertainty and align with MFDS and ICH standards, establishing us as a trusted GCP compliance partner for clinical trials in South Korea.
Computer System Validation (CSV) Services in South Korea for GxP Compliance
In South Korea’s evolving pharmaceutical and clinical research field, digital systems in clinical trials and manufacturing must ensure reliability, security, and regulatory compliance as mandated by the Ministry of Food and Drug Safety (MFDS). The authorities have enforced strict computerized system validation (CSV) requirements within the Korea Good Clinical Practice (KGCP) and Korea Good Manufacturing Practice (KGMP) frameworks, aligning with ICH guidelines and US 21 CFR Part 11. Zenovel offers expert CSV services to help GxP systems meet MFDS expectations and international standards while enhancing operational efficiency.
Our CSV Services in South Korea Include:
- Validation planning, risk assessment & IQ/OQ/PQ execution
- Lifecycle documentation for EDC, CTMS, LIMS, eTMF, and ERP platforms
- Data integrity, system controls & electronic record compliance (aligned with MFDS electronic record guidance)
- Audit‑ready, scalable validation integrated with your quality strategy
Zenovel validates systems to ensure audit readiness, scalability, and compliance with Korean and global quality standards. By collaborating with IT, QA, and clinical teams, we minimize validation delays, bolster compliance, and enhance inspection readiness for MFDS audits and international regulatory reviews, providing a robust foundation for critical decision-making.
GCP Audit Services in South Korea for Clinical Trial Compliance & Quality Assurance
We make every step easier and regulatory-compliant with our GCP Audit services in South Korea
Clinical trials in South Korea are regulated by the Ministry of Food and Drug Safety (MFDS) under Korea Good Clinical Practice (KGCP) guidelines, aligned with ICH E6(R3). As a top global clinical trial destination, MFDS emphasizes GCP compliance through inspections and updated requirements. Zenovel offers GCP audit services to help sponsors, CROs, and sites identify and resolve compliance issues before MFDS evaluations.
- Site audits, sponsor audits, vendor audits & system-level quality reviews
- Alignment with ICH E6(R3) guidelines, KGCP, MFDS regulations, and WHO standards
- Assessment of protocol adherence, informed consent processes, documentation accuracy & data integrity
- CAPA development, risk‑based quality improvement & inspection readiness planning
Zenovel specializes in identifying and addressing compliance gaps in clinical operations, ensuring organizations are audit-ready for MFDS inspections. With expertise in clinical quality assurance and GCP compliance in South Korea, we mitigate regulatory risks, enhance operational discipline, and strengthen sponsor confidence, making Zenovel a trusted partner for GCP audits and trial integrity.
CRO Set-up & Upgradation in South Korea for Maintaining GCP Compliance
Accelerating Korea's Clinical Trials by Building Compliant CROs
Upholding or establishing a Clinical Research Organization (CRO) in South Korea necessitates adherence to the MFDS regulations and KGCP guidelines, aligned with ICH E6(R3). As the 6th global clinical trial hub, South Korea emphasizes strict GCP compliance, risk-based quality management, and inspection readiness. Zenovel offers comprehensive support for ensuring GCP compliance and operational excellence in new or existing CROs.
Our CRO Setup & Upgradation Services for GCP Compliance in South Korea Include:
- Operational framework design & quality management system (QMS) setup
- SOP development aligned with MFDS, KGCP, ICH E6(R3), and WHO GCP standards
- Risk‑based monitoring (RBM) integration & vendor management frameworks
- Inspection readiness planning & mock MFDS GCP audit support
- Scalable, audit‑ready clinical trial infrastructure
At Zenovel, we associate with clinical, QA, and regulatory teams to develop compliance systems that meet MFDS standards and global benchmarks, ensuring your CRO is ready for inspections and performance-oriented from study start-up to close-out.
Be fully prepared before the inspection arrives.
PK‑Stat Review Services in South Korea for Seamless Clinical Data Analysis
We Offer Reliable PK‑Stat Solutions for High‑Quality Clinical Research in South Korea
In clinical development, minor errors in pharmacokinetic interpretation can greatly impact dosing decisions and regulatory outcomes. Zenovel’s PK-Stat review services in South Korea offer precise pharmacokinetic analysis compliant with MFDS, KGCP guidelines, and ICH standards, ensuring clinical data meets local and global regulatory expectations.
- Non‑compartmental analysis (NCA) & population PK modeling
- PK/PD evaluation aligned with MFDS and global expectations
- Clinical biostatistics and data review for accuracy and validation
- CDISC compliance (SDTM/ADaM) & submission‑ready outputs
At Zenovel, we focus on interpreting data with a scientific and regulatory emphasis, collaborating with clinical pharmacology and biostatistics teams to ensure data integrity and improve decision-making in clinical trials at both early and late stages. We are a trusted PK-Stat and biostatistics partner in South Korea.
Pre‑Inspection Readiness Services in South Korea for GCP Compliance
We Assist You in Preparing Your Studies for Confident GCP Inspections in Vietnam
Regulatory inspections are decisive events, emphasizing the importance of readiness in clinical systems before an auditor’s arrival. Zenovel provides pre-inspection readiness services in South Korea to enhance GCP compliance before regulatory audits. Our offerings align with the Ministry of Food and Drug Safety (MFDS), Korea Good Clinical Practice (KGCP), and ICH E6(R3) guidelines, assisting sponsors, CROs, and sites in identifying and mitigating compliance risks ahead of MFDS evaluations.
Our Pre‑Inspection Readiness Services in South Korea Include:
- Comprehensive gap assessments & mock regulatory inspections (MFDS‑style)
- Documentation reviews & quality system evaluations
- Assessment of informed consent, protocol adherence, data integrity & vendor oversight
- CAPA effectiveness review & inspection response strategy
Zenovel enhances quality management system (QMS) processes by simulating regulatory scrutiny in collaboration with clinical and quality teams. We prioritize inspection success in the South Korean market, offering a readiness partnership rather than mere consultancy. Consult Zenovel for a smooth transition through regulatory inspections.
Risk‑Based Monitoring (RBM) Services in South Korea for Seamless Clinical Trials
We Enhance Clinical Monitoring with Stringent Data‑Driven RBM in South Korea
The requirement of Risk-Based Monitoring (RBM) services in South Korea addresses the challenges of traditional monitoring methods that may slow down trials and overlook crucial risks.
At Zenovel, our approach enhances clinical oversight by ensuring patient safety and data quality. Zenovel’s RBM services are aligned with the Ministry of Food and Drug Safety (MFDS), Korea Good Clinical Practice (KGCP), and ICH E6(R3) guidelines.
Our RBM Services in South Korea Include:
- Centralized monitoring & key risk indicator (KRI) development
- Site risk assessment & real‑time data review strategies
- Alignment with MFDS expectations and ICH E6(R3) guidelines
- Transition from routine on‑site to data‑driven, risk‑proportionate monitoring
Zenovel partners with clinical operations and data management teams to develop risk-based monitoring (RBM) plans aimed at enhancing issue detection and trial efficiency in multi-site studies. This strategy promotes early risk identification, optimal resource use, and improved regulatory compliance, positioning Zenovel as a strategic ally for efficient and compliant clinical trials in South Korea.
Sponsor Oversight Services in South Korea for Clinical Trial Governance
We enhance clinical trial governance in South Korea through reliable sponsor oversight.
Maintaining true oversight is challenging when multiple vendors, sites, and CROs are involved in a trial, beyond just running it. Zenovel’s sponsor oversight services in South Korea ensure complete visibility, control, and accountability for sponsors, aligning with the Ministry of Food and Drug Safety (MFDS), Korea Good Clinical Practice (KGCP), and ICH E6(R3) guidelines.
Our Sponsor Oversight Services in South Korea Include:
- CRO performance oversight & vendor management
- Quality monitoring & risk‑based governance frameworks
- KPI tracking, responsibility mapping & consistent execution oversight
- Alignment with ICH E6(R3) guidelines and MFDS expectations
Zenovel collaborates with sponsor teams to improve quality systems, communication, and risk management in clinical trials in South Korea, serving as a dependable oversight partner with expertise in governance, accountability, and inspection readiness for complex clinical operations.
Good Manufacturing Practice (GMP) Services in South Korea for Pharma Compliance
We support pharmaceutical manufacturers in South Korea by ensuring compliance with GMP standards.
In South Korea, pharmaceutical manufacturing is regulated by the MFDS in accordance with KGMP standards, which align with WHO GMP and PIC/S guidelines. Zenovel offers GMP services to assist pharmaceutical and biotech companies in achieving compliance and enhancing operational reliability.
Our GMP Services in South Korea Include:
- GMP audits, quality system (QMS) design & review
- Deviation management, CAPA implementation & documentation control
- Alignment with MFDS, KGMP, PIC/S, WHO GMP, and global standards
- Inspection readiness support & risk‑based compliance frameworks
Zenovel collaborates with quality and manufacturing teams to enhance compliance systems, mitigate risks, and ensure consistency through practical, risk-based strategies that emphasize real regulatory outcomes rather than just theoretical compliance.
We are your reliable GMP partner in South Korea for manufacturing and inspection-ready operations.
GMP Audit Services in South Korea for Manufacturing Quality Assurance
GMP Audit Services in South Korea for Manufacturing Quality Assurance
Pharmaceutical manufacturing in South Korea is regulated by the Ministry of Food and Drug Safety (MFDS), with strict penalties for quality lapses. Zenovel offers GMP audit services to ensure compliance with MFDS regulations, Korea Good Manufacturing Practice (KGMP), and international standards through expert assessments of manufacturing quality assurance.
- Production processes & quality management systems (QMS)
- Documentation control, batch records & CAPA effectiveness
- Vendor quality systems & root cause analysis of compliance risks
- Alignment with current MFDS Circulars and KGMP/PIC/S requirements
Zenovel views audits as opportunities for regulatory intelligence, leveraging experienced experts in pharmaceutical quality assurance to optimize manufacturing environments for MFDS or global inspections. We act as your GMP quality assurance partner in South Korea, enhancing audit confidence through expert validation.
Pharma Plant Setup & Upgradation Services in South Korea
Elevating Pharmaceutical Facilities to Global and Regulatory-Compliant GMP Standards in South Korea
Establishing or upgrading a pharmaceutical manufacturing facility in South Korea requires compliance with regulations set by the MFDS, including adherence to KGMP, PIC/S, WHO GMP, and international standards. Zenovel offers comprehensive services for creating GMP-compliant, scalable, and inspection-ready manufacturing environments throughout the setup process in South Korea.
- Plant design review, cleanroom classification & HVAC validation
- Equipment qualification (IQ/OQ/PQ) & QMS integration
- For existing facilities: modernization, gap closure, contamination control & process optimization
- Alignment with MFDS, KGMP, PIC/S, WHO GMP, and global standards
Zenovel leverages engineering and regulatory expertise to enhance operational efficiency and compliance, preparing facilities for audits. Collaborating with manufacturing, QA, and validation teams, we aim to minimize regulatory risks and expedite processes.
We invite you to partner with us in establishing or transforming a GMP-compliant manufacturing site in South Korea.
Pre‑Inspection Readiness Services for GMP Compliance in South Korea
We Assist in GMP Inspection Readiness and Assure Compliance Confidence in South Korea
Regulatory inspections are vital, and poor preparation can result in findings, delays, or setbacks in studies. The pre-inspection readiness services in South Korea guarantee that clinical trials remain compliant and prepared for inspections at all times.
- Gap analysis of the quality system, production process, and documentation
- Audit trail & CAPA system evaluation
- mock inspection support (MFDS‑style) & GMP audit support
- Continuous compliance improvement for MFDS and KGCP alignment
We assist sponsors, CROs, and sites in South Korea in enhancing quality systems, minimizing compliance risks, and confidently managing inspections.
Be fully prepared before the inspection arrives.
Clinical & Scientific Expert Services in South Korea for Drug Development
We offer expert clinical insight throughout every stage of development in South Korea.
To aid pharmaceutical and biotech companies in both early- and late-stage drug development, there is a need for clinical expert services in South Korea. Zenovel offers support that enhances drug development strategies, refines study designs, and expedites regulatory readiness, ensuring compliance with the Ministry of Food and Drug Safety (MFDS), Korea Good Clinical Practice (KGCP), and international ICH guidelines.
Our Clinical & Scientific Expert Services in South Korea Include:
- Clinical development strategy & protocol design
- PK/PD interpretation & translational science support
- Biomarker strategy, endpoint selection & study design optimization
- Regulatory scientific consulting aligned with MFDS and global guidelines
Zenovel partners with clinical, regulatory, and R&D teams to bridge preclinical research and clinical execution, basing recommendations on scientific reasoning and practical experience to improve development efficiency and reduce uncertainty. We serve as a reliable partner for science-driven drug development in South Korea.
Medical & Scientific Writing Services in South Korea for Regulatory Success
Regulatory submissions in South Korea necessitate precise data and well-structured documentation for communication with the MFDS. Zenovel provides medical and scientific writing services to pharma, biotech, and CROs, aiding in the transformation of complex clinical data into submission-ready documents that comply with MFDS standards, KGCP, and ICH guidelines, thereby expediting the approval process.
Our medical writing services include:
- Clinical study reports (CSR), protocols & investigator brochures (IB)
- Informed consent forms (ICF) & CTD/eCTD modules
- Pharmacovigilance documents & clinical summaries
- Full alignment with ICH guidelines and MFDS regulatory standards
Zenovel combines scientific knowledge with regulatory precision to create well-structured documents for efficient reviews and approvals. Serving as an extension of regulatory and clinical teams, Zenovel lightens the documentation load and improves submission quality, positioning itself as a dependable medical writing partner in South Korea for expedited regulatory reviews.
Preclinical Support Services in South Korea for Early-Stage Drug Development
We Streamline Early Drug Development with Expert Preclinical Support in South Korea
At Zenovel, our team assists biotech and pharmaceutical companies in moving from discovery to clinical readiness by providing comprehensive preclinical support services. These services blend scientific expertise with regulatory precision, resulting in reliable data packages that ease regulatory reviews and support successful IND submissions.
Our Preclinical Support Services in South Korea Include:
- In vitro & in vivo studies, toxicology assessment & PK/PD analysis
- Bioanalytical support & translational research
- Lead compound optimization, risk identification & safety evaluation
- Regulatory documentation aligned with MFDS, KGCP, and global standards
Zenovel’s integrated CRO preclinical support services in South Korea improve study design, reduce delays and costs, and enhance data accuracy, enabling faster transitions to clinical phases while ensuring compliance with MFDS, KGCP, and international standards for various therapies.
We establish ourselves as a reliable partner for clinical success in the region.
Regulatory Affairs & Compliance Services in South Korea for Global Submissions
We Speed up Global Submissions Through Regulatory Eminence Across South Korea
Navigating global regulations necessitates expertise, and Zenovel’s Regulatory Affairs & Compliance Services in South Korea assist pharmaceutical and biotech companies in product development and market authorization, ensuring efficient submissions with the MFDS and international entities like the FDA, EMA, and WHO.
Our Regulatory Affairs & Compliance Services in South Korea Include:
- eCTD dossier preparation, IND/CTA submissions & NDA/BLA support
- Labeling compliance, gap analysis, and regulatory intelligence
- Lifecycle management & post‑approval maintenance
- Alignment with MFDS, ICH, PIC/S, and global guidelines
We provide regulatory compliance services in South Korea to assist sponsors in reducing submission delays and regulatory risks. Our integrated approach enhances submission accuracy and facilitates expedited global expansion, leading to faster and compliant product approvals.
Dossier Due Diligence Services in South Korea for Regulatory Accuracy
A regulatory dossier that seems complete can still have minor inconsistencies, causing delays in review by the MFDS. Zenovel offers dossier due diligence services in South Korea, ensuring submissions comply with both national and global regulatory standards through comprehensive CTD/eCTD dossier review services.
Our Dossier Due Diligence Services in South Korea Include the Following:
- Clinical data consistency & CMC documentation alignment
- Module integration & ICH guideline compliance
- Gap analysis for missing evidence, contradictions & formatting issues
- Submission risk assessment & quality assurance
- Alignment with MFDS, PIC/S, and WHO requirements
Zenovel enhances submission strategies by working with regulatory, clinical, and CMC teams to improve documentation clarity and coherence. This collaboration reduces submission risks, improves quality assurance, and boosts confidence during reviews by MFDS and global health authorities, ensuring submissions are fully validated before reaching regulators in South Korea.
eCTD Compilation Services for Global Regulatory Submissions in South Korea
Offering You South Korea‑Based eCTD Expertise for Worldwide Regulatory Success
Streamline your regulatory approval process in South Korea with expert eCTD compilation services for pharmaceutical, biotech, and life sciences companies, ensuring accurate and compliant electronic submissions that meet MFDS and international standards for quicker market entry.
Our eCTD Compilation Services in South Korea include:
- Document formatting, module‑wise structuring & quality validation
- Hyperlinking, publishing & submission readiness for MFDS, PIC/S, and global authorities (FDA, EMA, WHO)
- IND, NDA, ANDA, and BLA dossier management for global filings
- Full compliance with evolving eCTD, ICH, and PIC/S guidelines
Zenovel specializes in global regulatory submissions, prioritizing accuracy and efficiency to minimize errors and delays. This enhances data integrity and accelerates approval processes, establishing Zenovel as a reliable partner for electronic submissions in South Korea.
Environmental Risk Assessment Services for Regulatory Compliance in South Korea
Bringing Compliance‑Driven ERA Services to South Korea
Pharmaceutical and biotech companies in South Korea need to engage Environmental Risk Assessment Services to comply with regulatory requirements and foster sustainable drug development. Increased oversight from the MFDS and adherence to international guidelines, such as the EU Environmental Risk Assessment framework, necessitate early evaluations of active pharmaceutical ingredients (APIs) and formulations for product approval and compliance with both national and global standards.
Our Environmental Risk Assessment Services in South Korea Include:
- Phase I & Phase II environmental assessments
- PEC/PNEC calculations & exposure modeling
- Ecotoxicity evaluation & regulatory dossier preparation
- Integration with global submission strategies (MFDS, PIC/S, WHO)
Integrating environmental compliance services early in development reduces approval risks and delays, boosting regulatory confidence for sponsors and CROs. Zenovel provides robust documentation for global submissions and lifecycle compliance, positioning itself as a trusted partner for accurate environmental assessments in South Korea.
EU QP Support Services for Batch Release Compliance in South Korea
Offering Expert EU QP Solutions for South Korean Pharmaceutical Compliance
Ensuring regulatory compliance for South Korean pharmaceutical companies exporting to Europe necessitates expert EU QP Support Services, as Qualified Person (QP) certification is crucial for EU imports. This certification ensures compliance with GMP standards before product release, following EU GMP Annex 16 requirements.
Our EU QP Support Services in South Korea Include:
- Batch record review & GMP compliance verification
- Deviation assessment & quality documentation review
- Coordination with EU Qualified Persons for final certification
- Alignment with EU GMP Annex 16 and global regulatory expectations
- Support for South Korean manufacturers targeting EU markets under MFDS export guidelines and KGMP standards
Zenovel utilizes our expertise in batch release compliance to reduce approval delays and compliance risks, enabling effective product distribution in Europe. Zenovel and our expert team assist South Korean pharmaceutical firms, CDMOs, and sponsors in maintaining regulatory standards; we act as a trusted QP support partner for compliant batch releases in the EU market.
Regulatory Gap Analysis Services in South Korea for Regulatory Compliance.
We Are Identifying Gaps and Strengthening Compliance in South Korea
To enhance submission success rates and identify compliance gaps early, Zenovel offers Regulatory Gap Analysis Services for pharmaceutical and biotech companies in South Korea. They assess clinical, non-clinical, and CMC documentation to ensure adherence to MFDS, KGCP, PIC/S guidelines, and global standards, which are essential for gaining timely approvals.
Our Regulatory Gap Analysis Services in South Korea Include:
- Dossier completeness & data integrity
- SOP compliance & submission readiness
- Gaps in IND, NDA, ANDA, and BLA applications (for global submissions)
- Actionable remediation plans for compliance optimization
- Alignment with MFDS, KGCP, PIC/S, ICH, and WHO requirements
Zenovel offers regulatory compliance services, aiding sponsors in minimizing approval risks and improving submission quality. We identify deficiencies and provide solutions to enhance regulatory positioning, ensuring audit-ready and globally compliant documentation. Additionally, our team conducts gap analysis in South Korea to avoid regulatory delays and support approval-ready submissions.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
